UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer

Histopathology, 2005-08, Vol.47 (2), p.141-146

2005

Volltextzugriff (PDF)

Microsatellite instability is associated with reduced disease specific survival in stage III colon cancer

European journal of surgical oncology, 2016-11, Vol.42 (11), p.1680-1686

2016

Volltextzugriff (PDF)

A Simplified Tumor Regression Grade Correlates with Survival in Locally Advanced Rectal Carcinoma Treated with Neoadjuvant Chemoradiotherapy

Annals of surgical oncology, 2008-12, Vol.15 (12), p.3471-3477

2008

Volltextzugriff (PDF)

Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up

Breast cancer research and treatment, 2016-04, Vol.156 (3), p.501-506

2016

Volltextzugriff (PDF)

Tumour microenvironment of both early- and late-stage colorectal cancer is equally immunosuppressive

British journal of cancer, 2014-08, Vol.111 (5), p.927-932

2014

Volltextzugriff (PDF)

Clinical factors associated with overall survival (OS) for patients with HER2-positive (HER2+) metastatic breast cancer (MBC) treated with HER2-targeting systemic therapy (HER2Tx)

European journal of cancer (1990), 2017-02, Vol.72, p.S44-S44

2017

Volltextzugriff (PDF)

Nuclear oxidative damage correlates with poor survival in colorectal cancer

British journal of cancer, 2009-01, Vol.100 (2), p.381-388

2009

Volltextzugriff (PDF)

1879 Impact of adjuvant trastuzumab (adjT) for early-stage (ES) breast cancer (BC) on clinical characteristics, survival and likelihood of durable complete response (DCR) of HER2-positive (HER2+) metastatic breast cancer (MBC): A 15-year single-institution cohort study

European journal of cancer (1990), 2015-09, Vol.51, p.S292-S293

2015

Volltextzugriff (PDF)

Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer

Journal of clinical oncology, 1997-01, Vol.15 (1), p.187-192

1997

Volltextzugriff (PDF)

Effects of CDX2 on prognosis and chemotherapy responsiveness in mismatch repair‐deficient colorectal cancer

BJS open, 2018-12, Vol.2 (6), p.456-463

2018

Volltextzugriff (PDF)

P5.11 A comparison of scales and measures for the assessment of chemotherapy induced peripheral neuropathy

Clinical neurophysiology, 2011, Vol.122, p.S80-S80

2011

Volltextzugriff (PDF)

Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin

European journal of cancer care, 2012-11, Vol.21 (6), p.782-789

2012

Volltextzugriff (PDF)

A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer

Cancer chemotherapy and pharmacology, 2007-01, Vol.59 (1), p.79-87

2007

Volltextzugriff (PDF)

P30-27 The effects of taxol (paclitaxel) on nerve excitability, nerve conduction studies, and clinical parameters

Clinical neurophysiology, 2010, Vol.121, p.S286-S286

2010

Volltextzugriff (PDF)

6133 POSTER High Levels of Immature Blood Vessels in Colorectal Tumours and Metastases Correlate With Survival and Are Independent of Oxidative Damage in the Tumour

European journal of cancer (1990), 2011, Vol.47, p.S432-S432

2011

Volltextzugriff (PDF)

1135 POSTER Proteomic Anlaysis of Differenially Expressed Proteins in Patients With Metastatic Colorectal Cancer Responding to Bevacizumab

European journal of cancer (1990), 2011, Vol.47, p.S134-S134

2011

Volltextzugriff (PDF)

1162 POSTER Frequency of Mitochondrial Point Mutations and Deletions in Late Stage Colorectal Cancer Patients

European journal of cancer (1990), 2011, Vol.47, p.S142-S142

2011

Volltextzugriff (PDF)

Extraskeletal Ewing's sarcoma : A case report and review of the literature

Spine (Philadelphia, Pa. 1976), 2000-08, Vol.25 (15), p.1996-1999

2000

Volltextzugriff (PDF)

Hepatocellular carcinoma complicating cystic fibrosis related liver disease

Journal of cystic fibrosis, 2009-07, Vol.8 (4), p.288-290

2009

Volltextzugriff (PDF)

Sequential Dose-Dense Doxorubicin, Paclitaxel, and Cyclophosphamide for Resectable High-Risk Breast Cancer: Feasibility and Efficacy

Journal of clinical oncology, 1999-01, Vol.17 (1), p.93-100

1999

Volltextzugriff (PDF)

Gastrointestinal perforation in metastatic carcinoma: A complication of bevacizumab therapy

European journal of surgical oncology, 2009-04, Vol.35 (4), p.444-446

2009

Volltextzugriff (PDF)

Primary cardiac lymphoma: diagnostic tools and treatment challenges

Irish journal of medical science, 2011-03, Vol.180 (1), p.271-273

2011

Volltextzugriff (PDF)

57P The efficacy and safety of pembrolizumab in advanced cervical cancer: A real-world treatment study

Annals of oncology, 2020-12, Vol.31, p.S1438-S1439

2020

Volltextzugriff (PDF)

310P Substantial reduction in the percentage of metastatic breast cancer (MBC) which is HER-2 positive (HER-2+) over two decades: Sequential cohort analysis from the 1000 patient HER-2 study

Annals of oncology, 2021-09, Vol.32, p.S499-S499

2021

Volltextzugriff (PDF)

A modified regimen of nab-paclitaxel and gemcitabine in advanced pancreatic cancer

Annals of oncology, 2016-10, Vol.27, p.vi226-vi226

2016

Volltextzugriff (PDF)

1 – 25 von 365

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(326)
Mit Volltextzugriff
(248)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(187)
Humans
(173)
Life Sciences & Biomedicine
(167)
Female
(121)
Male
(88)
Aged
(71)
Middle Aged
(67)
Biological And Medical Sciences
(66)
Adult
(63)
Medical Sciences
(61)
Oncology
(50)
Aged, 80 And Over
(33)
General & Internal Medicine
(26)
Animals
(25)
Tumors
(24)
Adolescent
(23)
Pharmacology. Drug Treatments
(21)
Prognosis
(21)
Treatment Outcome
(21)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer

Microsatellite instability is associated with reduced disease specific survival in stage III colon cancer

A Simplified Tumor Regression Grade Correlates with Survival in Locally Advanced Rectal Carcinoma Treated with Neoadjuvant Chemoradiotherapy

Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up

Tumour microenvironment of both early- and late-stage colorectal cancer is equally immunosuppressive

Clinical factors associated with overall survival (OS) for patients with HER2-positive (HER2+) metastatic breast cancer (MBC) treated with HER2-targeting systemic therapy (HER2Tx)

Nuclear oxidative damage correlates with poor survival in colorectal cancer

1879 Impact of adjuvant trastuzumab (adjT) for early-stage (ES) breast cancer (BC) on clinical characteristics, survival and likelihood of durable complete response (DCR) of HER2-positive (HER2+) metastatic breast cancer (MBC): A 15-year single-institution cohort study

Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer

Effects of CDX2 on prognosis and chemotherapy responsiveness in mismatch repair‐deficient colorectal cancer

P5.11 A comparison of scales and measures for the assessment of chemotherapy induced peripheral neuropathy

Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin

A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer

P30-27 The effects of taxol (paclitaxel) on nerve excitability, nerve conduction studies, and clinical parameters

6133 POSTER High Levels of Immature Blood Vessels in Colorectal Tumours and Metastases Correlate With Survival and Are Independent of Oxidative Damage in the Tumour

1135 POSTER Proteomic Anlaysis of Differenially Expressed Proteins in Patients With Metastatic Colorectal Cancer Responding to Bevacizumab

1162 POSTER Frequency of Mitochondrial Point Mutations and Deletions in Late Stage Colorectal Cancer Patients

Extraskeletal Ewing's sarcoma : A case report and review of the literature

Hepatocellular carcinoma complicating cystic fibrosis related liver disease

Sequential Dose-Dense Doxorubicin, Paclitaxel, and Cyclophosphamide for Resectable High-Risk Breast Cancer: Feasibility and Efficacy

Gastrointestinal perforation in metastatic carcinoma: A complication of bevacizumab therapy

Primary cardiac lymphoma: diagnostic tools and treatment challenges

57P The efficacy and safety of pembrolizumab in advanced cervical cancer: A real-world treatment study

310P Substantial reduction in the percentage of metastatic breast cancer (MBC) which is HER-2 positive (HER-2+) over two decades: Sequential cohort analysis from the 1000 patient HER-2 study

A modified regimen of nab-paclitaxel and gemcitabine in advanced pancreatic cancer

Suchergebnisse filtern